MedPath

Sexual Dysfunction and an Educational Program to Improve the Quality of Sexual Function in Vietnamese Pregnant Women in First Trimester

Not Applicable
Conditions
Female Sexual Dysfunction
Interventions
Behavioral: Educational program
Registration Number
NCT04419961
Lead Sponsor
National Hospital of Obstetrics and Gynecology
Brief Summary

Sexual dysfunction is common in pregnant women (46.6%, 34.4%, and 73.3% in women in the first, second, and third trimester worldwide, respectively). These dysfunctions can persist after childbirth, affecting quality of life, marriage satisfaction, and family happiness. In Vietnam, a country heavily influenced by the Eastern traditions, sexual activity is considered private and only shared between husband and wife. Many women have wrong beliefs that having sexual intercouse during pregnancy will affect the safety of the fetus, and thus, are reluctant to engage in sexual activity with their husband. Interventions have been developed to improve the quality of sexual function in pregnant women.

In Vietnam, data of sexual dysfunction in pregnant women are somewhat limited, and there have been no programs to improve the sexual function for this population. Therefore, the study team plans to develop an educational program with aim to improve the quality of sexual function in Vietnamese pregnant women. This study aims to investigate the prevalence and associated factors of sexual dysfunction in first-trimester pregnant women and evaluate the effectiveness of the educational program.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
350
Inclusion Criteria
  • Pregnant women whose gestational age is less than or equal to 12 weeks.
  • Currently living with husband/partner.
  • No signs and symptoms of first trimester complications (eg, threated abortion).
Exclusion Criteria
  • Getting pregnant from in vitro fertilization or having a history of preterm birth.
  • Having serious health conditions that require abortion.
  • Illiterate, or having mental illness or incapacity.
  • Having a fetus diagnosed with anomalies.
  • Does not agree to participate.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionEducational programRoutine care plus participation in an educational program including a group discussion and a booklet.
Primary Outcome Measures
NameTimeMethod
Change in the FSFI score from baseline to two monthsTwo months

Patients are followed up after two months and repeated the FSFI. The difference between the baseline total FSFI score and the two-month total FSFI score is calculated. The mean difference is calculated for the intervention and the control arm.

Prevalence of sexual dysfunction in pregnant womenBaseline

Sexual function is evaluated using the Female Sexual Function Index (FSFI). The FSFI includes 19 questions covering six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. Questions ask about participant's sexual experience during the past four weeks, rating the degree/frequency of their experience on a scale from "not at all" or "never" to "very" or "always". Four questions score 1-5 and fifteen score 0-5. Then, the scores of questions in an individual domain are added and the total score is multiplied by the domain factor. Finally, the six domain scores are added to obtain the full scale score. A total FSFI score of \<= 26.55 is considered sexual dysfunction.

Secondary Outcome Measures
NameTimeMethod
Change in knowledge and attitude at two monthsTwo months

Knowledge and attitude are assessed by asking participants whether they agree or disagree with 24 statements. These statements are developed based on the key messages of the educational program. K/A assessment is repeated at two months. We calculate the proportion of participants who have changes in knowledge and attitude after the educational program.

Trial Locations

Locations (1)

National Hospital of Obstetrics and Gynecology

🇻🇳

Hanoi, Vietnam

© Copyright 2025. All Rights Reserved by MedPath